Overview

The Renal Safety in Patients With Chronic HCV Undergoing Sofosbuvir Containing Antiviral Therapy

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study is to investigate the occurrence of AKI during antiviral therapy, when compared with baseline values in Egyptian patients. In addition, the study aims to evaluate the change in insulin resistance value after treating patients from HCV.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
MTI University
Treatments:
Antiviral Agents
Sofosbuvir
Criteria
Inclusion Criteria:

- Ageā‰„ 18 years Chronic infection with HCV GT 4 No prior HCV treatment experience

Exclusion Criteria:

- Co-infection with HBV or HIV, clinical evidence of ischemic heart disease, the
presence of diabetic ketoacidosis, Patients admitted to the intensive care unit (ICU),
or expected to undergo surgery during the study period, and Child Pough score C.